On February 1, 2023, the FTC announced a proposed $1.5 million settlement with GoodRx Holdings, based on alleged violations of the Federal Trade Commission Act (“FTC Act”) and Health Breach Notification Rule (“HBNR”) for using advertising technologies on its websites and mobile app that resulted in the unauthorized disclosure of consumers’ personal and health information to advertisers and other third parties. On the same day, the U.S. Department of Justice, acting on behalf of the FTC, filed a Complaint and Proposed Stipulated Order detailing the FTC’s allegations and the terms of the proposed settlement.
Blog Editors
Recent Updates
- Watch: Hemant Gupta Bridges the Gap Between Cutting-Edge Technology and Intellectual Property Protection
- A Proposed Overhaul to Federal Grantmaking: What It Could Mean for Grantees, Healthcare and Other Researchers, and Colleges and Universities
- Watch: Agencies Step Up DEI Scrutiny, DOL Clarifies Overtime Rules, and California Court Limits PAGA Claims - Employment Law This Week
- Virginia Pay Transparency Requirements Take Effect July 1, 2026
- Connecticut Joins Growing Number of States Regulating Workplace AI and Mandating Notice for Certain AI Uses as Well as Imposing New Disclosure Requirements for Certain Reductions in Force